<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03720509</url>
  </required_header>
  <id_info>
    <org_study_id>CA001HY</org_study_id>
    <nct_id>NCT03720509</nct_id>
  </id_info>
  <brief_title>A Study to Collect Information Related to the Cordio Medical System</brief_title>
  <official_title>A Multi-Center Observational Study to Collect Information Related to the Clinical Significance and Performance of the Cordio System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordio Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordio Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center observational non-interventional prospective study. A Single-arm,
      open, database establishment for R&amp;D purposes when R&amp;D data will be analyzed retrospectively
      for efficacy at the end of the study.

      The study will be conducted in the following settings: Hospital and at home.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 17, 2015</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>R&amp;D database for voice signal analysis</measure>
    <time_frame>throughout study, 1-2 years per patient</time_frame>
    <description>Building a sufficient R&amp;D database for device development. Recordings will be analyzed to create the patient voice signal signature (Hz)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usability- SUS (system usability scale)</measure>
    <time_frame>throughout study, 1-2 years per patient</time_frame>
    <description>Cordio Application usability data will be assessed as secondary performance endpoint using SUS scale (0-100 when higher results are better).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Heart Failureï¼ŒCongestive</condition>
  <arm_group>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cordio Medical</intervention_name>
    <description>All patients are recorded using the Cordio Medical app, no further intervention</description>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with NYHA 2-3 who are being followed-up at the Hospital. All patients must meet
        eligibility criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic Heart Failure Patient.

          -  Patient with reduced or preserved EF (ejection fraction) CHF (congestive heart
             failure).

          -  The patient is willing to participate as evidenced by signing the written informed
             consent.

          -  Male or non-pregnant female patient.

        Exclusion Criteria:

          -  Subject who, in the Investigator's opinion, unable to comply with the daily use of the
             App due to mental disorders (e.g., depression, dementia).

          -  Patient who has had a major cardiovascular event (e.g., myocardial infraction, stroke)
             within 3 months prior to screening visit.

          -  Subject likely to undergo heart transplantation/ LVAD within 6 months of Screening
             Visit.

          -  Subject with congenital heart disease or mechanical heart valve(s).

          -  Subject with known coagulation disorders.

          -  Subject with evidence of active Infection.

          -  Patient with severe alcohol or drug use.

          -  Psychological instability, inappropriate attitude or motivation.

          -  Patient with life threatening debilitating disease other than cardiac.

          -  Subject currently enrolled in another investigational device or drug trial that has
             not completed the primary endpoint or that clinically interferes with the current
             study endpoints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kleiner Schochat, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orit Ronen, MSc</last_name>
    <phone>972-3-5467163</phone>
    <email>orit@cordio-med.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Be'er Sheva</city>
        <zip>85025</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Marc Weinstein, Dr.</last_name>
      <phone>08-6404442</phone>
      <email>jmwein@bgu.ac.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kleiner Schochat, Prof.</last_name>
      <phone>04-6304484</phone>
      <email>Shochat@hy.health.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

